Advertisement

TOLERABILITY, SAFETY, AND LUNG FUNCTION RESPONSE OF REVEFENACIN AND FORMOTEROL VIA NEBULIZATION IN PATIENTS WITH MODERATE TO VERY SEVERE COPD: A SUBGROUP ANALYSIS OF A PHASE 3 TRIAL

      SESSION TITLE: Obstructive Lung Disease Posters
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect